Get started
AETERNA ZENTARIS INCAETERNA ZENTARIS INCAETERNA ZENTARIS INC

AETERNA ZENTARIS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

AEZS chart

Key stats

Market capitalization
‪13.11 M‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.61CAD
Net income
‪−22.34 M‬CAD
Revenue
‪6.07 M‬CAD
Shares float
‪4.85 M‬
Beta (1Y)
0.85

About AETERNA ZENTARIS INC

Sector
Health Technology
CEO
Klaus Wolfgang Paulini
Headquarters
Toronto
Website
zentaris.com
Employees (FY)
21
Founded
1990
ISIN
CA0079755017
FIGI
BBG000BG2J61
Æterna Zentaris, Inc. is a specialty biopharmaceutical company, which engages in the development and commercialization of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AEZS is 2.70 CAD — it has decreased by 3.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange AETERNA ZENTARIS INC stocks are traded under the ticker AEZS.
AETERNA ZENTARIS INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
AEZS earnings for the last quarter are −1.15 CAD whereas the estimation was −0.83 CAD which accounts for −39.34% surprise. Estimated earnings for the next quarter are −1.29 CAD. See more details about AETERNA ZENTARIS INC earnings.
AETERNA ZENTARIS INC revenue for the last quarter amounts to ‪2.92 M‬ CAD despite the estimated figure of ‪1.51 M‬ CAD. In the next quarter revenue is expected to reach ‪3.10 M‬ CAD.
Yes, you can track AETERNA ZENTARIS INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, AEZS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AETERNA ZENTARIS INC stock right from TradingView charts — choose your broker and connect to your account.
AEZS reached its all-time high on Mar 14, 2000 with the price of 324750.00 CAD, and its all-time low was 1.91 CAD and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 21.00 employees. See our rating of the largest employees — is AETERNA ZENTARIS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AETERNA ZENTARIS INC EBITDA is ‪−24.11 M‬ CAD, and current EBITDA margin is −396.60%. See more stats in AETERNA ZENTARIS INC financial statements.